USPTO serial 79297420
ANMI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 1, 2021
- Examiner
- FOSS, KATHERINE M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ANMI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer | ACTIVE | — |
| 010 | Medical apparatus, namely, infusion and injection devices sold empty for administering drugs and diagnostic radiopharmaceuticals, namely, syringes; apparatus for medical purposes, namely, drug delivery devices sold empty for diagnostic radiopharmaceuticals, namely, syringes; medical devices for treating cancer; diagnostic imaging apparatus for medical use | ACTIVE | — |
| 042 | Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science all of the aforementioned in relation to radiopharmaceuticals and cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Telix Pharmaceuticals Limited
- Other trademarks owned by Telix Pharmaceuticals Limited
- Other trademarks owned by Telix Pharmaceuticals Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named ANMI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 1, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 26, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 14, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 25, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 23, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 23, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 1, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 1, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 16, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 16, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 15, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 24, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 24, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 24, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 9, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 9, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 9, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 9, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 25, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 25, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 5, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 5, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 4, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 30, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 28, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 5, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |